Allen DG and Monteiro-Riviere NA. Alteration of cytokeratin expression following transdermal lidocaine hydrochloride iontophoresis. Pharm Res 16: 1487-1490, 1999.
Ashburn MA, Gauthier M, Love G, Basta S, Gaylord B, and Kessler K. Iontophoretic administration of 2% lidocaine HCL and 1:100,000 epinephrine in humans. Clin J Pain 13: 22-26, 1997.
Avitall B, Hare J, Zander G, Bbockoff C, Tchou P, Jazayeri M, and Akhtar M. Iontophoertic transmyocardial drug therapy: A novel approach to antiarrhytmic drug therapy. Circulation 85: 1582-1593, 1992.
Bagniefski T and Burnette RA. Comparison of pulsed and continuous current iontophoresis. J Cardiovasc Release 11: 113-122, 1990.
Banga AK and Chien YW. Iontophoretic delivery of drugs: Fundamentals, developments, and biomedical applications. J Controlled Release 7: 1-24, 1988a.
Banga AK and Chien YW. Systemic delivery of therapeutic peptides and proteins. Int J Pharm 48: 15-50, 1988b.
Banga AK, Chien YW, Siddiqui O, Sun Y, Shi WM, and Liu JC. Transdermal iontophoretic delivery of therapeutic peptides/proteins: I. Insulin. Ann NY Acad Sci 507: 32-51, 1987.
Behl CR, Kumar S, Malick AW, del Terzo S, Higuchi WI, and Nash RA. Iontophoretic delivery: Effects of physiochemical factors on the skin uptake of nonpeptide drugs. J Pharm Sci 78: 355-360, 1989.
Brand RM and Guy RH. Iontophoresis of nicotine in vitro: Pulsatile drug delivery across the skin. J Control Release 33: 285-292, 1995.
Chang SL, Hofmann GA, Zhang L, Deftos LJ, and Banga AJ. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 66: 127-133, 2000.
Chesnoy S, Durand D, Doucet J, and Couarraze G. Structural parameters involved in the permeation of propoanalol HCL by iontophoresis and enhancers. J Controlled Release 58: 163-175, 1999.
Chien YW. Systemic delivery of peptide-based pharmaceuticals by transdermal periodic iontophoretic system. In Gurny R and Teubner A, Eds., Dermal and transdermal drug delivery. Stuttgart: Wiss.Verl.-Ges, 1993.
Chien YW and Banga AK. Iontophoretic (transdermal) delivery of drugs: Overview of historical development. J Pharm Sci 78: 353-354, 1989a.
Chien YW, Siddiqui O, Shi WM, Lelawongs P, and Liu JC. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J Pharm Sci 78: 376-383, 1989b.
Costello CT and Jeske AH. Iontophoresis: Applications in transdermal medication delivery. Phys Ther 75: 554-563, 1995.
Craane-van Hinsberg WHM, Bax L, Flinterman NHM, Verhoef J, Junginger HE, and Bodde HE. Iontophoresis of a model peptide across human skin in vitro: Effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance. Pharm Res 11: 1296-1300, 1994.
Cullander C. What are the pathways of iontophoretic current flowthrough the mammalian skin? Adv Drug Deliv Rev 9: 119-135, 1992.
Denuzzio JD and Berner B. Electrochemical and iontophoretic studies of human skin. J Controlled Release 11: 105-112, 1990.
Edelberg R. Electrical properties of Skin. In Elden HR, Ed., Biophysical properties of the skin. New York: Wiley, 1971.
Faes TJ, Van Der Meij HA, de Munck JC, and Heethar RM. The electric resistivity of human tissues (100 Hz-10 Mhz): A meta-analysis of review studies. Physiol Meas 20: R1-R10, 1999.
Fernandez-Ortiz A, Beat JM, Chesebro J, Fuster V, and Badimon JJ. Potential applications of iontophoresis for local drug delivery of vascualar diseases. J Intervent Cardiol 8: 420-426, 1995.
Fernandez-Ortiz A, Beat JM, Mailhac A, Falk E, Badimon L, Fallon JT, Fuster V, Chesebro JH, and Badimon JJ. A new approach for local intravascular drug delivery: Iontophoretic balloon. Circulation 89: 1518-1522, 1994.
Gangarosa LP. Defining a practical solution for iontophoretic local anesthesia of skin. Methods findings exp clin pharmacol 3: 83-94, 1981.
Gangarosa LP, No-Hee P, Wiggins CA, and Hill JM. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (Iontohydrokinesis). J Pharmacol Exp Ther 212: 377-381, 1980.
Gardiner TW, Armstrong-James M, Woodburn Caan A, Wightman RM, and Rebec GV. Modulation of neostriatal activity by iontophoresis of ascorbic acid. Brain Res 344: 181-185, 1985.
Geddes LA and Baker LE. The specific resistance of biological material-A compendium of data for the biomedical engineer and physiologist. Med Biol Eng 5: 271-293, 1967.
Grimnes S. Pathways of ionic flow through human skin in vivo. Acta Derm Venereol 64: 93-98, 1984.
Green PG. Iontophoretic delivery of peptide drugs. J Controlled Release 41: 33-48, 1996.
Greene PG, Hinz RS, Cullander C, Yamanae G, and Guy RH. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm Res 8: 1113-1120, 1991.
Gupta SK, Kumar S, Bolton S, Behl CR, and Malick AW. Optimization of iontophoretic transdermal delivery of a peptide and a non-peptide drug. J Control Release 30: 253-261, 1994.
Hodgkin DD, Pierpont GL, Hildebrand KR, and Gornick CC. Electrophysiologic characteristics of a pulsed iontophoretic drug-delivery system in coronary arteries. J Cardiovasc Pharmacol 29: 39-44, 1997.
Hoogstraate AJ, Srinivasan V, Sims SM, and Higuchi WI. Iontophoretic enhancement of peptides: Behaviour of leuprolide versus model permeants. J Control Release 31: 41-47, 1994.
Howard JP, Drake TR, and Kellogg DL. Effects of alternating current iontophoresis on drug delivery. Arch Phys Med Rehab 76: 463-466, 1995.
Huang YY, Wu SM, Wang CY, and Jiang TS. A strategy to optimize the operation conditions in iontophoretic transdermal delivery of pilocarpine. Drug dev ind pharm 21: 1631-1648, 1995.
Kalia YN and Guy RH. The electrical characteristics of human skin in vivo. Pharm Res 12: 1605-1613, 1995.
Kassan DG, Lynch AM, and Stiller MJ. Physical enhancement of dermatologic drug delivery: Iontophoresis and phonophoresis. J Am Acad Dermatol 34: 657-666, 1996.
Lai PM and Roberts MS. An analysis of solute structure-human epidermal transport relationships in epidermal iontophoresis using the ionic mobility: Pore model. J Control Release 58: 323-333, 1999.
Langkjaer L, Brange J, Grodsky GM, and Guy RH. Iontophoresis of monomeric insulin analogues in vitro: Effects of insulin charge and skin pretreatment. J Control Release 51: 47-56, 1998.
Lawler JC, Davis MJ, and Griffith EC. Electrical characteristics of the skin: The impedance of the surface sheath and deep tissues. J Invest Dermatol 34: 301-308, 1960.
Lelawongs P, Liu JC, and Chien YW. Transdermal iontophoretic delivery of arginine-vasopressin (II): Evaluation of electrical and operational factors. Int J Pharm 61: 179-188, 1990.
Liu JC, Sun Y, Siddiqui O, Chien YW, Shi W, and Li J. Blood glucose in diabetic rats by transdermal iontophoretic delivery of insulin. Int J Pharm 44: 197-204, 1988.
Lykken DT. Square-wave analysis of skin impedance. Psychophysiology 7: 262-275, 1970.
Mitchel JF, Azrin MA, Fram DB, Bow LM, and McKay RG. Localized delivery of heparin to angioplasty sites with iontophoresis. Catheterization Cardiovasc Diagn 41: 315-323, 1997.
Morimoto Y, Numajiri S, and Sugibayashi K. Effect of ion Species and their concentration on the iontophoretic transport of benzoic acid through poly (vinyl acetate) membrane. Chem Pharmacol Bull 39: 2412-2416, 1991.
Murthy SN. Magnetophoresis: An approach to enhance transdermal drug diffusion. Pharmazie 54: 377-379, 1999.
Nair V, Pillai O, Poduri R, and Panchagnula R. Transdermal iontophoresis. Part 1: Basic principles and considerations. Methods Findings Exp Clin Pharmacol 21: 139-151, 1999.
Numajiri S, Sakurai H, Sugibayashi K, Morimoto Y, Omiya H, Takenaka H, and Akiyama N. Comparison of depolarizing and direct current systems on iontophoretic enhancement of transport of sodium benzoate through human and hairless Rat skin. J Pharm Pharmacol 45: 610-613, 1993.
Okabe K, Yamaguchi H, and Kawai Y. New iontophoretic transdermal administration of the beta-blocker metoprolol. J Control Release 4: 79-85, 1986.
Pierce RC and Rebec GV. Iontophoresis in the neostriatum of awake, unrestrained Rats: Differential effects of dopamine, glutamate and ascorbate on motor-and nonmotor-related neurons. Neuroscience 67: 313-324, 1995.
Pikal MJ. The role of electrosmotic flow in transdermal iontophoreis. Adv Drug Deliv Rev 9: 201-237, 1992.
Pliquett U and Weaver JC. Transport of a charged molecule across the human epidermis due to electroporation. J Control Release 38: 1-10, 1996.
Pliquett UF, Gusbeth CA, and Weaver JC. Non-linearity of molecular transport through human skin due to electric stimulus. J Controlled Release 68: 373-386, 2000.
Pliquett UF, Vanbever R, Preat V, and Weaver JC. Local transport regions (LTRs) in human stratum corneum due to long and short “high voltage” pulses. Bioelectrochem Bioenerg 47: 151-161, 1998.
Plutchik R and Hirsh HR. Skin impedance and phase angle as a function of frequency and current. Science 141: 927-928, 1963.
Prausnitz MR, Edelman ER, Gimm JA, Langer R, and Weaver JC. Transdermal delivery of heparin by skin electroporation. Biotechnology 13: 1205-1209, 1995.
Prausnitz MR, Pliquett U, Langer R, and Weaver JC. Rapid temporal control of transdermal drug delivery by electroporation. Pharm Res 11: 1834-1837, 1994.
Price GJ. Sonochemistry and drug delivery. In Duck FA, Baker AC, and Starritt HZ, Eds., Ultrasound and Medicine. Philadelphia: Institute of physics publishing, 1997.
Reinauer S, Neusser A, Schauf G, and Holzle E. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): A new approach for the treatment of hyperhidrosis. Br J Dermatol 129: 166-169, 1993.
Riviere JE and Heit MC. Electrically-assisted transdermal drug delivery. Pharm Res 14: 687-697, 1997.
Riviere JE, Monteiro-Riviere NA, and Inman AO. Determination of lidocaine concentrations in skin after transdermal iontophoresis: Effects of vasoactive drugs. Pharm Res 9: 211-214, 1992.
Rosell J, Columinas J, Riu P, Pallas-Areny R, and Webster JG. Skin impedance from 1 Hz to 1 MHz. IEEE Trans Biomed Eng 35: 649-651, 1988.
Rosendal T. Concluding studies on the conducting properties of human skin to alternating current. Acta Phys Scand 9: 39-49, 1945.
Rosendal T. Studies on the conducting properties of the human skin to direct current. Acta Phys Scand 5: 130-151, 1943.
Saraf S and Dixit VK. Influence of electrical factors on in vitro iontophoretic delivery of timolol maleate. Drug Dev Ind Pharm 22: 175-179, 1996.
Scott ER, Laplaza AI, White HS, and Phipps JB. Transport of ionic species in skin: Contribution of pores to the overall skin conductance. Pharm Res 10: 1699-1709, 1993.
Scott N. Current status and potential applications of drug delivery balloon catheters. J Intervent Cardiol 8: 406-419, 1995.
Sharata HH and Burnette RR. Effect of dipolar aprotic permeability enhancers on the basal stratum corneum. J Pharm Sci 77: 27-32, 1988.
Shi W. The Physical Basis of Transdermal Periodic Iontophoretic Drug Delivery and Its Application to Diabetic and Hypertension Studies, PhD. Thesis, Rutgers University, 1988.
Siddiqui O, Sun Y, Liu J-C, and Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci 76: 341-345, 1987.
Sims SM, Higuchi WI, and Srinivasan V. Skin alteration and convective solvent flow effects during iontophoresis: I. neutral solute transport across human skin. Int J Pharm 69: 109-121, 1991.
Singh J. Effect of pH on iontophoretic and passive transport of p-am Benzoic acid through full thickness rat skin. Pharmazie 45: 634-635, 1990.
Singh J and Roberts MS. Transdermal delivery of drugs by iontophoresis: A review. Drug Design Deliv 4: 1-12, 1989.
Singh S, Bi M, Jayaswal SB, and Singh J. Effect of current densisty on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis. Int J Pharm 166: 157-166, 1998.
Srinivasan V, Higuchi WI, Sims SM, Ghanem AH, and Behl CR. Transdermal iontophoretic drug delivery: Mechanistic analysis and application to polypeptide delivery. J Pharm Sci 78: 370-375, 1989.
Srinivasan V, Su MH, Higuchi, WI, and Behl CR. Iontophoresis of polypeptides: Effect of ethanol pretreatment of human skin. J Pharm Sci 79: 588-591, 1990.
Sun Y and Xue H. Important parameters affecting iontophoretic transdermal delivery of insulin. Proc Int Symp Controlled Release Bioact Mater 17: 202-203, 1990.
Thysman S, Tasset C, and Preat V. Transdermal iontophoresis of fentanyl: Delivery and mechanistic analysis. Int J Pharm 101: 105-113, 1994.
Tregear RT. Interpretation of skin. impedance measurements. Nature 205: 600-601, 1965.
Tregear RT. Physical Functions of the Skin. New York: Academic Press, 1966.
Tyle P. Iontophoretic devices for drug delivery. Pharm Res 3: 318-326, 1986.
van Boxtel A. Skin resistance during square-wave electrical pulses of 1 to 10 mA. Med Biol Eng Comput 15: 679-687, 1977.
Vanbever R, Langers G, Montmayeur S, and Preat V. Transdermal delivery of fentanyl: Rapid onset of analgesia using skin electroporation. J Controlled Release 50: 225-235, 1998.
Wahlberg JE. Transepidermal or transfollicular absorption?: In vivo and in vitro studies in hairy and non-hairy guinea Pig skin with sodium (22Na) and mercuric (203Hg) chlorides. Acta Derm Venerol 48: 336-344, 1968.
Wang S, Kara M, and Krishnan TR. Transdermal delivery of cyclosporin-A using electroporation. J Control Release 50: 61-70, 1998.
Weaver JC, Vaughan TE, and Chizmadzhev Y. Theory of electrical creation of aqueous pathways across skin transport barriers. Adv Drug Deliv Rev 35: 21-39, 1999.
Wertz PW and Downing DT. Stratum corneum: Biological and biochemical considerations. In Hadgraft J, Guy RH, Eds., Transdermal Drug Delivery: Developmental Issues and Research Initiatives. New York: Marcel Dekker, 1989.
Yamamoto T and Yamamoto Y. Dielectric constant and resistivity of epidermal stratum corneum. Med Biol Eng 14: 494-499, 1976.
Yamamoto T and Yamamoto Y. Analysis for the change of skin impedance. Med Biol Eng Comput 15: 219-227, 1977.
Yamamoto T and Yamamoto Y. Dispersion and correlation of the parameters for skin impedance. Med and Biol Eng Comput 16: 592-594, 1978.
Yamamoto T and Yamamoto Y. Non-linear electrical properies of the skin in the low frequencty range. Med Biol Eng Comput 19: 302-310, 1981.
Yamamoto Y. Measurement and analysis of skin electrical impedance. Acta Derm Venereol Suppl (Stockh) 185: 34-38, 1994.
Yoshida NH and Roberts MS. Structure-transport relationships in transdermal iontophoresis. Adv Drug Deliv Rev 9: 239-264, 1992.
Zakzewski CA and Li JK-J. Pulsed mode constant current iontophoretic transdermal metoprolol tartrate delivery in established acute hypertensive Rabbits. J Controlled Release 17: 157-162, 1991.
Zakzewski CA, Wasilewski J, Cawley P, and Ford W. Transdermal delivery of regular insulin to chronic diabetic Rats: Effect of skin preparation and electrical enhancement. J Control Release 50: 267-272, 1998.
Zakzewski C, Amory DW, Jasaitis DK, and Li JK-J. Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive Rabbits: Preliminary report. Cardiovasc Drugs Ther 6: 589-595, 1992.
Zakzewski C, Li JK-J, Amory DW, Jensen JC, and Kalatzis-Manolakis E. Design and implementation of a constant-current pulsed iontophoretic stimulation device. Med Biol Eng Comput 34: 484-488, 1996.